Bruker expects first-quarter revenue to be $795 million to $800 million, ahead of Wall Street expectations. Analysts polled by FactSet are forecasting $758.4 million in quarterly revenue. The ...

Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company’s ...

At the ESCMID Global 2025 conference, Bruker´s Microbiology and Infection Diagnostics division is announcing the expansion of ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker (BRKR) to $50 from $60 and keeps an Overweight rating on the shares as ...

Bruker Corporation’s BRKR share price has dipped by 11.48%, which has investors questioning if this is right time to buy.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

Detailed price information for Mettler-Toledo International (MTD-N) from The Globe and Mail including charting and trades.

Bruker (NASDAQ:BRKR – Free Report) had its price target decreased by Citigroup from $75.00 to $50.00 in a research note published on Monday morning,Benzinga reports. Citigroup currently has a buy ...

Discover how Bruker’s BRAVO handheld Raman spectrometer is transforming material analysis with advanced fluorescence suppression and more.

ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, ...

Citi lowered the firm’s price target on Bruker (BRKR) to $50 from $75 and keeps a Buy rating on the shares as part of a Q1 preview for the life ...